Investing.com -- U.S. equities markets fell broadly on Friday closing lower for a fourth consecutive session, as lagging performances from stocks in the Basic Materials, Health Care and Energy industries weighed on the major indices.
The Dow Jones Industrial Average posted mild losses to remain in negative territory for the year, while the NASDAQ Composite index and the S&P 500 Composite index each fell by more than 1% to extend prior losses on the week. The Dow lost 163.39 or 0.92% to close at 17,568.39, while the NASDAQ dropped 57.78 or 1.12% to end the week at 5,088.63.
The S&P 500 fell 22.50 or 1.07%, as all 10 sectors closed in the red. Stocks in the Health Care, Basic Materials and Energy industries lagged, each falling more than 2% on the session.
Amazon.com Inc (NASDAQ:AMZN) shares skyrocketed as much as 20.4% to an all-time high of $580.57 after attaining unexpected profits when its quarterly earnings were released on Thursday after the bell. Amazon, which ended the session as the top performer on the NASDAQ and the S&P 500, fell back slightly to close at 529.42, up 47.24 or 9.80%.
The top performer on the Dow was Visa Inc (NYSE:V), which rose more than 4.2% to 74.80 after reporting stronger than expected earnings on Thursday after the close. The worst performer was DD, which fell 1.54 or 2.63% to 56.94.
On the NASDAQ, Amazon finished just ahead of Vodafone Group (LONDON:VOD) PLC (NASDAQ:VOD) which gained 0.72 or 1.99% to 36.91. The worst performer was Biogen Inc (NASDAQ:BIIB), which plunged to a seven-month low after slashing sales expectations fo its Multiple Sclerosis drug Tecfidera amid slowing demand. Shares in Biogen fell more than 22% to close on Friday at 300.03.
On the S&P 500, New Jersey-based medical equipment manufacturer BCR jumped more than 4% to 187.75 after beating analysts' forecasts with its second quarter earnings. C.R Bard finished just below Amazon as the top performer of the session. Biogen also finished as the worst performer on the S&P 500, just above travel website TRIP, which plummeted 12.51 or 13.40% to 80.86. Earlier this week, Trip Advisor's reported quarterly earnings below analysts' expectations amid soaring costs during the period.
On the New York Stock Exchange, declining issues outnumbered advancing ones by a 2,299 to 858 margin.